Funds with similar focus
Fund Name | Location |
3D Systems | Rock Hill, South Carolina, United States |
Azalea Capital | Greenville, South Carolina, United States |
C & G Capital Partners | Alabama, Tuscaloosa, United States |
CareDx | Brisbane, California, United States |
Dajian Investment | China, Qingpu, Shanghai |
Fortum | Boston, Massachusetts, United States |
Foyer | Canton Esch-sur-Alzette, Leudelange, Luxembourg |
Henan Maisheng Medical Technology | - |
Jacaranda Partners | California, Pasadena, United States |
Kiwi II Venture Capital | - |
Leshi Qiche | - |
National Bank of Oman | - |
Optum Ventures | Boston, Massachusetts, United States |
Ruchuan Capital | China, Fujian, Xiamen |
Split Rock Partners | Minneapolis, Minnesota, United States |
Teuza | Hefa, Hefa, Israel |
Veritas Technologies | California, Mountain View, United States |
VM Digital | Austria, Salzburg, Schwarzach |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Vesigen Therapeutics | $28M | 22 Jul 2020 | Cambridge, Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Vesigen Therapeutics | $28M | 22 Jul 2020 | Cambridge, Massachusetts, United States |